LIFE Atyr Pharma Inc

aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.

$2.80  0.00 (0.00%)
As of 05/26/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/07/2015
Outstanding shares:  28,056,249
Average volume:  87,381
Market cap:   $78,557,497
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -4.15
PB ratio:   0.80
PS ratio:   0.00
Return on equity:   -39.34%
Net income %:   -1,384,272.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy